New research improves our understanding of cancer cell regulation

January 10, 2018, University of Liverpool

A team of cancer researchers from the University of Liverpool, has made an important contribution to our understanding of cancer cell regulation which could better inform future cancer treatments.

The research is funded by North West Cancer Research, which has ring-fenced £180,000 for the three year-long project which started in 2015.

Led by Professor Ian Prior at the University of Liverpool, in collaboration with researchers at AstraZeneca, the research focuses on a group of proteins found in the human body called kinases.

Their research measures how changes in kinase activity can influence the growth, development and regulation of . They measure kinase network rewiring that occurs in cancer patients so that they can identify new strategies for killing .

Their insights into this important family of proteins have been published in the highly regarded Cancer Research Journal and will provide a foundation for future research on the use of kinases in cancer treatments.

Some kinases are currently being successfully targeted in cancer therapies, which work by inhibiting kinases that trigger cancer cells to divide and grow. Yet there is still a lot to learn about kinases and the important role they could play within future cancer treatments.

The research has been published in the journal of Cancer Research.

Professor Prior, NWCR Chair of Molecular Oncology at the University of Liverpool explains: "Our research focused on getting under the microscope of cancer cell behaviour and understanding the effects that different proteins can have on this behaviour.

"Research into kinases, has been underway for many years now, but most attention has been focussed on only a few types, with relatively little known about the remaining types.

"Our publication in the Cancer Research Journal, highlights emerging and overlooked areas within research and discusses the successes and challenges associated with treating ."

North West Cancer Research secured £4million of funding for projects across Merseyside and the North West in 2017.

This includes £1million of funding to sustain research at the North West Cancer Research Centre at the University of Liverpool until 2021.

Alastair Richards, CEO North West Cancer Research said: "As a funder of cancer research, we are always pleased to hear when projects we have supported generate important breakthroughs in our understanding of cancer.

"We are committed to funding only the best quality research to help the fight against cancer here in the North West. But we cannot do this alone. We rely solely on public donations - which is why every penny we raise is so important.

"Without the help of our supporters and fundraisers we would not be able to continue to support the lifesaving research which is being carried out on our doorstep today."

Explore further: New kinase detection method helps identify targets for developing cancer drugs

More information: Leah J. Wilson et al, New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome, Cancer Research (2017). DOI: 10.1158/0008-5472.CAN-17-2291

Related Stories

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Versatile cancer drugs

December 1, 2017
Medications that block enzymes belonging to the kinase family are among the most effective pharmaceuticals for targeted cancer therapies. Scientists at the German Cancer Consortium (DKTK) at the Technical University of Munich ...

New role of protein kinases in embryo development and cancer

January 7, 2016
A group of protein kinases have been found to play an important role in embryo development and may even be a potential cancer drug target, says research led by Queen Mary University of London (QMUL) and the Francis Crick ...

New tool to probe cancer's molecular make-up

August 26, 2014
Scientists have shown how to better identify and measure vital molecules that control cell behaviour – paving the way for improved tools for diagnosis, prediction and monitoring of cancer.

Study identifies potential therapeutic targets for metastatic prostate cancer

December 2, 2015
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have pinpointed five specific enzymes called protein kinases that play a role when prostate cancer spreads to bone. The discovery ...

Map of substrate-kinase interactions may lead to more effective cancer drugs

March 27, 2012
(Medical Xpress) -- Later-stage cancers thrive by finding detours around roadblocks that cancer drugs put in their path, but a Purdue University biochemist is creating maps that will help drugmakers close more routes and ...

Recommended for you

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

October 12, 2018
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.